Donanemab in early-onset Alzheimer’s disease | NEJM – nejm.org

by



[ad_1]

  1. Donanemab in early-onset Alzheimer’s disease | NEJMnejm.org
  2. Investigational Alzheimer’s Drug May Slow Cognitive Decline in Patients, Early Results SuggestCNN
  3. US limits supply of Eli Lilly’s anti-COVID-19 antibodies in three statesYahoo! Voice
  4. Eli Lilly releases detailed findings on Alzheimer’s drug, as data divides researchersSTAT
  5. US restricts Lilly antibody orders in 3 states over mutant concernBloomberg
  6. View full coverage on Google News

[ad_2]

Source link